Cabozantinib is a targeted kinase inhibitor used to treat several advanced cancers by blocking specific proteins that promote cell growth and tumor blood vessel formation. It is primarily prescribed for advanced kidney cancer, specific types of liver cancer, and certain thyroid and neuroendocrine tumors.